Dr. Thomas G. Westbrook, M.D.
Allergy & Immunology (Allergy & Immunology Physician)
- Medicare participating
At a glance
- Years since graduation
- 44
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 638
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Allergy & Immunology Physician primary
FL license ME50944
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Sacred Heart Hospital Pensacola, FL
Medical groups
- Premier Allergist of Florida LLC (21 clinicians)
- Southern Allergy and Asthma PC (3 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 638
- Services billed
- 41,574
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Test for allergy using allergenic extract | 4,640 | 73 |
| Professional service for preparation and provision of 1 or more antigens | 1,649 | 80 |
| Professional service for single injection of allergen | 796 | 63 |
| Professional service for multiple injections of allergen | 771 | 61 |
| Established patient office or other outpatient visit, 20-29 minutes | 350 | 277 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 329 | 223 |
| Established patient office or other outpatient visit, 30-39 minutes | 307 | 233 |
| Test to determine lung volumes using sensors | 126 | 117 |
| Test to examine how well the lungs exchange gases | 109 | 103 |
| Injection of drug or substance under skin or into muscle | 84 | 30 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Fluticasone Propionate Other prescribers in Pensacola, FL | 159 |
| Montelukast Sodium Other prescribers in Pensacola, FL | 123 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Pensacola, FL | 109 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Pensacola, FL | 92 |
| Azelastine Hcl Other prescribers in Pensacola, FL | 73 |
| Spiriva Respimat (tiotropium bromide) Other prescribers in Pensacola, FL | 58 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Pensacola, FL | 48 |
| Levocetirizine Dihydrochloride Other prescribers in Pensacola, FL | 45 |
| Ipratropium Bromide Other prescribers in Pensacola, FL | 42 |
| Dupixent Pen (dupilumab) Other prescribers in Pensacola, FL | 40 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 18 companies reported 180 payments worth $80,113 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $40,106 |
|---|---|
| Regeneron Healthcare Solutions, Inc. | $16,597 |
| Csl Behring | $12,824 |
| Pharming Healthcare, Inc. | $4,998 |
| Grifols USA, LLC | $3,519 |
| Genzyme Corporation | $847 |
| GlaxoSmithKline, LLC. | $246 |
| Novartis Pharmaceuticals Corporation | $213 |
| Compensation for services other than consulting (speaking, faculty) | $56,876 |
|---|---|
| Consulting Fee | $16,041 |
| Food and Beverage | $4,942 |
| Travel and Lodging | $2,195 |
| Education | $60.42 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. Oct 14, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $6,396 |
| Csl Behring Nov 20, 2025 | Consulting Fee Andembry · Hematology | $5,752 |
| Regeneron Healthcare Solutions, Inc. Aug 12, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $5,597 |
| Pharming Healthcare, Inc. Jul 31, 2025 | Consulting Fee RUCONEST · BIOLOGIC | $4,613 |
| AstraZeneca Pharmaceuticals LP Oct 15, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
| AstraZeneca Pharmaceuticals LP Mar 19, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
| AstraZeneca Pharmaceuticals LP Jul 15, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
| AstraZeneca Pharmaceuticals LP Aug 18, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
| AstraZeneca Pharmaceuticals LP May 2, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
| AstraZeneca Pharmaceuticals LP Feb 6, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
All 44 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Genzyme Corporation Dec 10, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $533 |
| Csl Behring Nov 25, 2025 | Consulting Fee Hizentra · Immunology | $2,365 |
| AstraZeneca Pharmaceuticals LP Nov 24, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $450 |
| Csl Behring Nov 20, 2025 | Consulting Fee Andembry · Hematology | $5,752 |
| Csl Behring Nov 20, 2025 | Consulting Fee Hizentra · Immunology | $3,311 |
| Grifols USA, LLC Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) Prolastin-C Liquid · Pulmonology | $3,135 |
| Csl Behring Nov 20, 2025 | Travel and Lodging Andembry · Hematology · travel to Atlanta, GA | $30.99 |
| Csl Behring Nov 20, 2025 | Travel and Lodging Andembry · Hematology · travel to Atlanta, GA | $22.96 |
| AstraZeneca Pharmaceuticals LP Oct 15, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
| Regeneron Healthcare Solutions, Inc. Oct 14, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $6,396 |
| AstraZeneca Pharmaceuticals LP Oct 2, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $125 |
| Csl Behring Sep 27, 2025 | Travel and Lodging Andembry · Hematology · travel to Atlanta, GA · in-kind | $592 |
| Csl Behring Sep 17, 2025 | Education Andembry · Hematology · in-kind | $60.42 |
| AstraZeneca Pharmaceuticals LP Sep 3, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $3,250 |
| AstraZeneca Pharmaceuticals LP Aug 18, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
| Regeneron Healthcare Solutions, Inc. Aug 12, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $5,597 |
| AstraZeneca Pharmaceuticals LP Aug 12, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $250 |
| Pharming Healthcare, Inc. Jul 31, 2025 | Consulting Fee RUCONEST · BIOLOGIC | $4,613 |
| Pharming Healthcare, Inc. Jul 31, 2025 | Travel and Lodging RUCONEST · BIOLOGIC · travel to PENSACOLA, FL · in-kind | $30.00 |
| AstraZeneca Pharmaceuticals LP Jul 15, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
| AstraZeneca Pharmaceuticals LP Jul 10, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Gainesville, FL · in-kind Company’s descriptionSpeaker Expenses | $468 |
| AstraZeneca Pharmaceuticals LP Jul 10, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Gainesville, FL · in-kind Company’s descriptionSpeaker Expenses | $228 |
| Regeneron Healthcare Solutions, Inc. Jun 6, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $800 |
| AstraZeneca Pharmaceuticals LP May 21, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $450 |
| AstraZeneca Pharmaceuticals LP May 2, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
| Regeneron Healthcare Solutions, Inc. Apr 18, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,999 |
| Regeneron Healthcare Solutions, Inc. Apr 15, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $1,341 |
| AstraZeneca Pharmaceuticals LP Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $2,800 |
| AstraZeneca Pharmaceuticals LP Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $125 |
| AstraZeneca Pharmaceuticals LP Apr 7, 2025 | Travel and Lodging AIRSUPRA · Respiratory · travel to Destin, FL · in-kind Company’s descriptionSpeaker Expenses | $74.06 |
| AstraZeneca Pharmaceuticals LP Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $3,250 |
| AstraZeneca Pharmaceuticals LP Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $100 |
| AstraZeneca Pharmaceuticals LP Mar 19, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
| AstraZeneca Pharmaceuticals LP Mar 4, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $3,250 |
| AstraZeneca Pharmaceuticals LP Feb 26, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Fort Lauderdale, FL · in-kind Company’s descriptionSpeaker Expenses | $393 |
| AstraZeneca Pharmaceuticals LP Feb 26, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Fort Lauderdale, FL · in-kind Company’s descriptionSpeaker Expenses | $154 |
| AstraZeneca Pharmaceuticals LP Feb 26, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Fort Lauderdale, FL · in-kind Company’s descriptionSpeaker Expenses | $15.94 |
| AstraZeneca Pharmaceuticals LP Feb 25, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $250 |
| AstraZeneca Pharmaceuticals LP Feb 18, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $450 |
| AstraZeneca Pharmaceuticals LP Feb 18, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $125 |
| AstraZeneca Pharmaceuticals LP Feb 11, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to TAVARES, FL · in-kind Company’s descriptionSpeaker Expenses | $63.28 |
| AstraZeneca Pharmaceuticals LP Feb 6, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $3,700 |
| Regeneron Healthcare Solutions, Inc. Feb 4, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to LAKE CITY, FL · in-kind | $111 |
| AstraZeneca Pharmaceuticals LP Feb 4, 2025 | Travel and Lodging AIRSUPRA; TEZSPIRE · Respiratory · travel to Ocala, FL · in-kind Company’s descriptionSpeaker Expenses | $11.48 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $93,696 in research payments for these studies, mostly to the institutions running them.
- Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Sanofi US Services Inc. · Active, not recruiting · NCT06676319
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.